LEADER 03851nam 2200937z- 450 001 9910566461803321 005 20220506 035 $a(CKB)5680000000037763 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/81165 035 $a(oapen)doab81165 035 $a(EXLCZ)995680000000037763 100 $a20202205d2022 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aMarine Anti-inflammatory and Antioxidant Agents 2021 210 $aBasel$cMDPI - Multidisciplinary Digital Publishing Institute$d2022 215 $a1 online resource (172 p.) 311 08$a3-0365-3373-7 311 08$a3-0365-3374-5 330 $aThe Special Issue "Marine Anti-Inflammatory and Antioxidants Agents 2021" collected the latest research, both in vitro and in vivo, on natural compounds from a variety of deep-sea organisms with anti-inflammatory and/or antioxidant properties as potential candidates for new drug discovery, and more generally for the field of marine biotechnology. The research presented here discusses the potential benefits of certain peptides and proteins derived from oysters, blue mussels, and cyanobacteria, as well as the carotenoid pigment astaxanthin, which is found in a variety of marine organisms. This Special Issue has carved out an important space for crude extracts from marine products, such as microalgae and green algae, highlighting their potential benefits to human health. Finally, the Special Issue includes a review of the benefits of some natural compounds derived from the algal biome against inflammatory bowel diseases, as well as a research article identifying the presence of the OvoA gene in arthropods for the first time. Through an excursus of high-quality research, this Special Issue provides the entire scientific community with new tools and insights to catch a molecular treasure for human health from the sea. 606 $aMedicine and Nursing$2bicssc 606 $aPharmacology$2bicssc 610 $aacute kidney injury 610 $aacute liver injury 610 $aalgal biome 610 $aantioxidant 610 $aapoptosis 610 $aastaxanthin 610 $abioactive entities 610 $abioactive peptide 610 $ablue mussel 610 $aC-phycoerythrin 610 $acytoprotective 610 $aD-galactose 610 $adendritic cells 610 $aendoplasmic reticulum stress 610 $aendothelial dysfunction 610 $aengineered cues 610 $aferroptosis 610 $afucoxanthin 610 $ahormone 610 $aimmune dysfunction 610 $ainflammation 610 $ainflammatory bowel disease 610 $akidney 610 $alipopolysaccharide 610 $amercury 610 $amicroalgae 610 $amicroRNA 610 $an/a 610 $anatural products 610 $aoxidative stress 610 $aoyster 610 $aoyster peptides 610 $apeptide 610 $aPhormidium persicinum 610 $apolysaccharide 610 $apolysaccharides 610 $apyroptosis 610 $aRAW 264.7 610 $asepsis 610 $aspermatogenesis 610 $atestis 610 $atherapeutic attributes 610 $aTisochrysis lutea 610 $atranscriptome mining 610 $aUlva lactuca 610 $azooplankton 615 7$aMedicine and Nursing 615 7$aPharmacology 700 $aDegl'Innocenti$b Donatella$4edt$01289227 702 $aVasarri$b Marzia$4edt 702 $aDegl'Innocenti$b Donatella$4oth 702 $aVasarri$b Marzia$4oth 906 $aBOOK 912 $a9910566461803321 996 $aMarine Anti-inflammatory and Antioxidant Agents 2021$93031703 997 $aUNINA